Financhill
Sell
50

CVS Quote, Financials, Valuation and Earnings

Last price:
$67.75
Seasonality move :
2.69%
Day range:
$66.52 - $67.91
52-week range:
$43.56 - $80.75
Dividend yield:
3.96%
P/E ratio:
18.34x
P/S ratio:
0.23x
P/B ratio:
1.12x
Volume:
6.5M
Avg. volume:
8.8M
1-year change:
-15.82%
Market cap:
$84.6B
Revenue:
$372.8B
EPS (TTM):
$3.66

Earnings Data

Next earnings date for CVS
May 01
2025
Most recent earnings per share
$1.30
Beat by $0.38
(Feb 12/2025)
Consensus Estimate
$0.92
(Feb 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CVS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $95.2B -- -- $1.58 --
05/01/2025 Q1 $93.1B -- -- $1.62 --
02/12/2025 Q4 $96.9B $97.7B $1.30 $0.92 $0.38
11/06/2024 Q3 $92.7B $95.4B $0.07 $1.45 -$1.38
08/07/2024 Q2 $91.4B $91.2B $1.41 $1.73 -$0.32
05/01/2024 Q1 $89.2B $88.4B $0.88 $1.70 -$0.82
02/07/2024 Q4 $90.7B $93.8B $1.58 $1.99 -$0.41
11/01/2023 Q3 -- -- $1.75 $2.13 -$0.38
08/02/2023 Q2 -- -- $1.48 $2.12 -$0.64
05/03/2023 Q1 -- -- $1.65 $2.09 -$0.44
02/08/2023 Q4 -- -- $1.75 $1.93 -$0.18
11/02/2022 Q3 -- -- -$2.60 $1.99 -$4.59
08/03/2022 Q2 -- -- $2.23 $2.18 $0.05
05/04/2022 Q1 -- -- $1.74 $2.15 -$0.41
02/09/2022 Q4 -- -- $0.98 $1.88 -$0.90
11/03/2021 Q3 -- -- $1.20 $1.79 -$0.59
08/04/2021 Q2 -- -- $2.10 $2.07 $0.03
05/04/2021 Q1 -- -- $1.68 $1.77 -$0.09
02/16/2021 Q4 -- -- $0.74 $1.24 -$0.50
11/06/2020 Q3 -- -- $0.93 $1.34 -$0.41
08/05/2020 Q2 -- -- $2.26 $1.92 $0.34
05/06/2020 Q1 -- -- $1.53 $1.63 -$0.10
02/12/2020 Q4 -- -- $1.33 $1.69 -$0.36
11/06/2019 Q3 -- -- $1.17 $1.77 -$0.60
08/07/2019 Q2 -- -- $1.49 $1.69 -$0.20
05/01/2019 Q1 -- -- $1.09 $1.51 -$0.42
02/20/2019 Q4 -- -- -$0.37 -- --
11/06/2018 Q3 -- -- $1.36 -- --
08/08/2018 Q2 -- -- -$2.52 -- --
05/02/2018 Q1 -- -- $0.98 -- --
02/08/2018 Q4 -- -- $3.22 -- --
11/06/2017 Q3 -- -- $1.26 -- --
08/08/2017 Q2 -- -- $1.07 -- --
05/02/2017 Q1 -- -- $0.92 -- --
02/09/2017 Q4 -- -- $1.59 -- --
11/08/2016 Q3 -- -- $1.43 -- --
08/02/2016 Q2 -- -- $0.86 -- --
05/02/2016 Q1 -- -- $1.04 -- --
02/09/2016 Q4 -- -- $1.34 -- --
10/30/2015 Q3 -- -- $1.11 -- --
08/04/2015 Q2 -- -- $1.12 -- --

CVS Health Earnings Questions

  • How Much did CVS Health Generate in Revenue Last Quarter?

    CVS Health reported $97.7B worth of top line sales in its most recent quarter.

  • Did CVS Health Beat Earnings Last Quarter?

    CVS Health announced earnings per share of $1.30 which represents a beat of analyst forecast a $0.92 per share.

  • Is CVS Health Profitable?

    CVS Health reported $12.9B that represents $10.22 per share over the last quarter.

  • What is the Analyst Consensus for CVS Health EPS Next Year?

    CVS Health's earnings are forecast to grow from $3.66 per share to $5.18 per share next year representing an increase of 61.21%.

  • When is CVS Health's Earnings Date?

    CVS Health's next earnings date is May 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 31

Ajinomoto [AJINY] is down 2.15% over the past day.

Sell
40
RGC alert for Mar 31

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
69
AGX alert for Mar 31

Argan [AGX] is down 4.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock